Clinical Trial Update: QUILT-2.016: Study of AMG 479 With Biologics or Chemotherapy for Subjects With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating AMG 479 in combination with biologics or chemotherapy for subjects with advanced solid tumors; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• AMG 479

Snippet

Sponsor: NantCell, Inc. | Conditions: Advanced Malignancy, Advanced Solid Tumors | Phase 1 | Status: COMPLETED